Evidence map›Paper›PMID 39844643›Full record

ArticleActa biochimica et biophysica Sinica2025

Immunopathological characteristics and therapeutic effects of UC-MSCs in a pigeon breeder's lung mouse model.

Jingran Xu, Li Li, Yaping Zhou, Zulipikaer Abudureheman, Lexin Xue, Chao Wu, Xiaoguang Zou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jingran XuThe First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Li LiDepartment of Respiratory and Critical Care Medicine, First People's Hospital of Kashi, Kashi 844000, China.
Yaping ZhouDepartment of Respiratory and Critical Care Medicine, First People's Hospital of Kashi, Kashi 844000, China.
Zulipikaer AbudurehemanClinical Research Center of Infectious Diseases (Pulmonary Tuberculosis), First People's Hospital of Kashi, Kashi 844000, China.
Lexin XueDepartment of Respiratory and Critical Care Medicine, First People's Hospital of Kashi, Kashi 844000, China.
Chao WuDepartment of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Shihezi University, Shihezi 832061, China.
Xiaoguang ZouDepartment of Respiratory and Critical Care Medicine, First People's Hospital of Kashi, Kashi 844000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypersensitivity pneumonitis (HP), including pigeon breeder's lung (PBL), often progresses from acute inflammation to fibrosis, impairing lung function and limiting targeted therapeutic strategies. Mechanistic studies on PBL progression are limited by the lack of preclinical animal models and a predominant focus on patient data. This study explores the immunopathological characteristics of all stages of PBL in mice and evaluates the therapeutic potential of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) during the non-fibrotic stage. PBL models are created in A/J mice through tracheal instillation of pigeon dropping extract (PDE) protein powder. Different doses (0.4 × 10

Indexed as

Bird Fancier's LungLungMesenchymal Stem CellsMesenchymal Stem Cell TransplantationUmbilical CordAnimalsColumbidaeDisease Models, AnimalHumansMaleMiceimmunopathologypigeon breeder’s lungtherapyUC-MSC

Identifiers

PMID39844643
PMCPMC11986440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.